Welcome to Innovacell Biotechnologie AG

Innovacell Biotechnologie AG is an innovative biotechnology company that develops personalized cell therapies for treatment of ‎incontinence.‎ Innovacell is running multinational clinical trials for its two ‘tissue-engineered’ products in development, ICES13 and ICEF15. Using Innovacell’s innovative ‘ultrasound-guided’ injector, patients benefit from a minimally invasive surgery. More than 500 patients have been treated since 2002.

Cures for Incontinence

News